Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma

(2013) Luigi Bolondi et al.   DIGESTIVE AND LIVER DISEASE

Hepatocellular Carcinoma Responding to Superselective Transarterial Chemoembolization: An Issue of Nodule Dimension?

(2013) Rita Golfieri et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis

(2012) Katerina Malagari et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

(2012) Hashem B. El-Serag   GASTROENTEROLOGY

Can we trust in trials stopped early for benefit?

(2012) Giovanni Casazza et al.   Internal and Emergency Medicine

Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

(2012) Myeong Jun Song et al.   JOURNAL OF HEPATOLOGY

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design

(2012) Marta Burrel et al.   JOURNAL OF HEPATOLOGY

1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

(2012) J.M. Llovet et al.   JOURNAL OF HEPATOLOGY

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

(2011) Mario Scartozzi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines

(2011) Kenichi Takayasu et al.   JOURNAL OF HEPATOLOGY

Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma

(2011) Rodolfo Sacco et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

(2009) Johannes Lammer et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros

(2009) María Varela et al.   MEDICINA CLINICA

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)

(2008) M. Doffoël et al.   EUROPEAN JOURNAL OF CANCER